Want to track AVIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Atea Pharmaceuticals Inc. (AVIR) Statistics
Valuation metrics
Market Cap 412.14M
Enterprise value 336.02M
Trailing P/E (ttm) -2.48
Forward P/E -
PEG ratio 0.1
Price/Sales (ttm) -
Price/Book (mrq) 2.02
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.96
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 287.67K
Average volume (90 days) 286.13K
Price summary
52-Week low 2.87
52-Week high 6.45
Beta -
50-Day moving average 5.15
200-Day moving average 5.2
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.71%
Return on equity -0.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.74
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 8.13%
Book value per share (mrq) 2.55
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
